Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
EMA
Biotech
More collaborative FDA can accelerate rare disease R&D: report
The National Academies is recommending the FDA and European Medicines Agency implement a “navigation service” to advise on regulatory pathways.
Nick Paul Taylor
Sep 13, 2024 5:00am
PTC deepens layoffs as DMD drug faces loss of EU authorization
Sep 29, 2023 8:51am
CureVac giving up on first COVID mRNA vaccine
Oct 12, 2021 7:40am
Parexel hiring spree continues as it nabs regulator alumni
Jul 27, 2020 8:20am
EMA starts accelerated review of Gilead's remdesivir
May 1, 2020 6:00am
As Brexit nears, Britain's drugs, devices and pricing regulators seek the exit
Aug 22, 2019 9:00am
